THELPER AS

Norway922432244Active

Developing innovative antiviral antibody drug conjugates for aggressive solid tumors.

Biotechnology Startupthelper.com

Overview

Unknown
Employees
5.8M NOK
Revenue
2019
Founded

Key Decision Makers

Katja Vetvik

Founder and CEO

@thelper.com+47957XXXXX

Description

Thelper AS is a Norwegian biotechnology company focused on developing innovative treatments for incurable cancers. They specialize in first-in-class antiviral antibody drug conjugates that target virally encoded biomarkers found in aggressive solid tumors. By identifying markers absent in healthy ti...

Tags

B2BPharmaceuticalsWhite Collar

Keywords

ADCAntibody Drug ConjugatesAntiviral TherapyBiopharmaBiotechnologyCancer ResearchCancer TherapeuticsCancer TreatmentDrug DevelopmentImmunosuppressionMetastasisNorwegian BiotechOncologyOncology StartupPrecision MedicinePreclinical ResearchSolid TumorsTargeted TherapyTherapeutic InnovationViral Biomarkers

Tech Stack

NGINXGoogle MapsFont AwesomePHPreCAPTCHA

Company Information

Industry
Unknown
Legal Form
Aksjeselskap
VAT Number
Unknown

Decision Makers

1 contacts in Funnelfeedr

Katja Vetvik

Founder and CEO

@thelper.com+47957XXXXX

Similar Companies

20 similar companies in Funnelfeedr

Browse More

THELPER AS Questions

Want to see Funnelfeedr in action?

Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.

Book a demo